- The U.S. government is preparing to launch vaccines for children below five in conjunction with educational and outreach efforts, pending approval by federal regulators, the Wall Street Journal reports.
- The government looks to provide ten million initial doses as the virus spreads nationwide, leaving the parents anxious.
- The vaccinations could begin by June 21, subject to the regulatory approval for Moderna, Inc (NASDAQ:MRNA), Pfizer, Inc (NYSE:PFE), and partner BioNTech SE (NASDAQ:BNTX).
- Equal amounts of vaccines from Pfizer and Moderna will be available on approval.
- Five million doses have been made available for preorders by states, community health centers, and pharmacies. Another five million doses will be made available for preorder.
- The government aimed to make them available through public-health clinics, community health centers, pharmacies including children’s hospitals, health systems, and pop-up clinics at children’s museums.
- Vaccination rates for children between 5 and 18 years trailed those for older people.
- An FDA advisory committee will meet on June 14-15 to review the vaccination data, followed by a CDC review on June 17-18.
- Price Action: MRNA shares traded higher by 1.25% at $150.38 in the premarket on the last check Thursday.
- Image by x3 from Pixabay
